Liver injury associated with kratom, a popular opioid-like product: Experience from the U.S. drug induced liver injury network and a review of the literature

Drug Alcohol Depend. 2021 Jan 1:218:108426. doi: 10.1016/j.drugalcdep.2020.108426. Epub 2020 Nov 23.

Abstract

Background: Kratom is a botanical product used as an opium substitute with abuse potential.

Methods: Assessment of suspected cases of kratom-induced liver injury in a prospective US cohort.

Results: Eleven cases of liver injury attributed to kratom were identified with a recent increase. The majority were male with median age 40 years. All were symptomatic and developed jaundice with a median latency of 14 days. The liver injury pattern was variable, most required hospitalization and all eventually recovered. Biochemical analysis revealed active kratom ingredients.

Conclusion: Kratom can cause severe liver injury with jaundice.

Keywords: 7-hydroxymitragynine; Hepatotoxicity; Kratom; Mitragynine; Opioid.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adult
  • Analgesics, Opioid / adverse effects
  • Chemical and Drug Induced Liver Injury / epidemiology*
  • Female
  • Humans
  • Male
  • Mitragyna / adverse effects*
  • Prospective Studies
  • United States / epidemiology

Substances

  • Analgesics, Opioid